| UniProt ID | NUDC_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y266 | |
| Protein Name | Nuclear migration protein nudC | |
| Gene Name | NUDC | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 331 | |
| Subcellular Localization | Cytoplasm, cytoskeleton. Nucleus. In a filamentous pattern adjacent to the nucleus of migrating cerebellar granule cells. Colocalizes with tubulin and dynein and with the microtubule organizing center. Distributed throughout the cytoplasm of non-migr | |
| Protein Description | Plays a role in neurogenesis and neuronal migration (By similarity). Necessary for correct formation of mitotic spindles and chromosome separation during mitosis. Necessary for cytokinesis and cell proliferation.. | |
| Protein Sequence | MGGEQEEERFDGMLLAMAQQHEGGVQELVNTFFSFLRRKTDFFIGGEEGMAEKLITQTFSHHNQLAQKTRREKRARQEAERREKAERAARLAKEAKSETSGPQIKELTDEEAERLQLEIDQKKDAENHEAQLKNGSLDSPGKQDTEEDEEEDEKDKGKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIEDGKVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENSKLSDLDSETRSMVEKMMYDQRQKSMGLPTSDEQKKQEILKKFMDQHPEMDFSKAKFN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 19 | Ubiquitination | GMLLAMAQQHEGGVQ HHHHHHHHHCCCHHH | 31.88 | 21890473 | |
| 24 | Ubiquitination | MAQQHEGGVQELVNT HHHHCCCHHHHHHHH | 18.23 | 22817900 | |
| 39 | 2-Hydroxyisobutyrylation | FFSFLRRKTDFFIGG HHHHHHHCCCEECCC | 46.11 | - | |
| 39 | Acetylation | FFSFLRRKTDFFIGG HHHHHHHCCCEECCC | 46.11 | 62135805 | |
| 39 | Ubiquitination | FFSFLRRKTDFFIGG HHHHHHHCCCEECCC | 46.11 | - | |
| 40 | Phosphorylation | FSFLRRKTDFFIGGE HHHHHHCCCEECCCC | 35.91 | - | |
| 47 | Ubiquitination | TDFFIGGEEGMAEKL CCEECCCCCCHHHHH | 46.28 | 24816145 | |
| 50 | Sulfoxidation | FIGGEEGMAEKLITQ ECCCCCCHHHHHHHH | 5.01 | 21406390 | |
| 53 | Ubiquitination | GEEGMAEKLITQTFS CCCCHHHHHHHHHHH | 35.33 | 29967540 | |
| 56 | Ubiquitination | GMAEKLITQTFSHHN CHHHHHHHHHHHHHH | 31.80 | 22817900 | |
| 58 | Phosphorylation | AEKLITQTFSHHNQL HHHHHHHHHHHHHHH | 20.60 | 28857561 | |
| 60 | Phosphorylation | KLITQTFSHHNQLAQ HHHHHHHHHHHHHHH | 27.50 | 28857561 | |
| 68 | 2-Hydroxyisobutyrylation | HHNQLAQKTRREKRA HHHHHHHHHHHHHHH | 38.09 | - | |
| 68 | Acetylation | HHNQLAQKTRREKRA HHHHHHHHHHHHHHH | 38.09 | 25953088 | |
| 68 | Ubiquitination | HHNQLAQKTRREKRA HHHHHHHHHHHHHHH | 38.09 | 21906983 | |
| 72 | Ubiquitination | LAQKTRREKRARQEA HHHHHHHHHHHHHHH | 43.53 | 21890473 | |
| 73 | Ubiquitination | AQKTRREKRARQEAE HHHHHHHHHHHHHHH | 49.93 | 22817900 | |
| 74 | Ubiquitination | QKTRREKRARQEAER HHHHHHHHHHHHHHH | 30.19 | 22817900 | |
| 76 | Ubiquitination | TRREKRARQEAERRE HHHHHHHHHHHHHHH | 38.62 | 21890473 | |
| 77 | Ubiquitination | RREKRARQEAERREK HHHHHHHHHHHHHHH | 53.95 | 22817900 | |
| 81 | Ubiquitination | RARQEAERREKAERA HHHHHHHHHHHHHHH | 60.14 | 22817900 | |
| 93 | Acetylation | ERAARLAKEAKSETS HHHHHHHHHHHHCCC | 63.90 | 11921613 | |
| 96 | Sumoylation | ARLAKEAKSETSGPQ HHHHHHHHHCCCCCC | 50.33 | - | |
| 96 | Sumoylation | ARLAKEAKSETSGPQ HHHHHHHHHCCCCCC | 50.33 | - | |
| 96 | Ubiquitination | ARLAKEAKSETSGPQ HHHHHHHHHCCCCCC | 50.33 | 33845483 | |
| 97 | Phosphorylation | RLAKEAKSETSGPQI HHHHHHHHCCCCCCH | 53.83 | 28985074 | |
| 99 | Phosphorylation | AKEAKSETSGPQIKE HHHHHHCCCCCCHHH | 46.18 | 25262027 | |
| 100 | Phosphorylation | KEAKSETSGPQIKEL HHHHHCCCCCCHHHC | 44.41 | 25627689 | |
| 100 | Ubiquitination | KEAKSETSGPQIKEL HHHHHCCCCCCHHHC | 44.41 | 24816145 | |
| 104 | Ubiquitination | SETSGPQIKELTDEE HCCCCCCHHHCCHHH | 4.16 | 24816145 | |
| 105 | Acetylation | ETSGPQIKELTDEEA CCCCCCHHHCCHHHH | 41.23 | 23236377 | |
| 105 | Ubiquitination | ETSGPQIKELTDEEA CCCCCCHHHCCHHHH | 41.23 | 21906983 | |
| 108 | Phosphorylation | GPQIKELTDEEAERL CCCHHHCCHHHHHHH | 42.32 | 29255136 | |
| 109 | Ubiquitination | PQIKELTDEEAERLQ CCHHHCCHHHHHHHH | 65.45 | 22817900 | |
| 113 | Ubiquitination | ELTDEEAERLQLEID HCCHHHHHHHHHHHH | 58.15 | 22817900 | |
| 122 | 2-Hydroxyisobutyrylation | LQLEIDQKKDAENHE HHHHHHHHHHHHHHH | 49.20 | - | |
| 122 | Acetylation | LQLEIDQKKDAENHE HHHHHHHHHHHHHHH | 49.20 | 25953088 | |
| 122 | Ubiquitination | LQLEIDQKKDAENHE HHHHHHHHHHHHHHH | 49.20 | 21906983 | |
| 123 | Ubiquitination | QLEIDQKKDAENHEA HHHHHHHHHHHHHHH | 57.44 | 22817900 | |
| 125 | Ubiquitination | EIDQKKDAENHEAQL HHHHHHHHHHHHHHH | 28.50 | 21890473 | |
| 126 | Ubiquitination | IDQKKDAENHEAQLK HHHHHHHHHHHHHHH | 70.07 | 22817900 | |
| 127 | Ubiquitination | DQKKDAENHEAQLKN HHHHHHHHHHHHHHC | 39.77 | 22817900 | |
| 129 | Ubiquitination | KKDAENHEAQLKNGS HHHHHHHHHHHHCCC | 50.09 | 21890473 | |
| 130 | Ubiquitination | KDAENHEAQLKNGSL HHHHHHHHHHHCCCC | 16.68 | 22817900 | |
| 131 | Ubiquitination | DAENHEAQLKNGSLD HHHHHHHHHHCCCCC | 50.41 | 22817900 | |
| 133 | Ubiquitination | ENHEAQLKNGSLDSP HHHHHHHHCCCCCCC | 47.37 | 32015554 | |
| 134 | Ubiquitination | NHEAQLKNGSLDSPG HHHHHHHCCCCCCCC | 54.61 | 22817900 | |
| 136 | Phosphorylation | EAQLKNGSLDSPGKQ HHHHHCCCCCCCCCC | 38.10 | 23927012 | |
| 139 | Phosphorylation | LKNGSLDSPGKQDTE HHCCCCCCCCCCCCC | 40.62 | 29255136 | |
| 145 | Phosphorylation | DSPGKQDTEEDEEED CCCCCCCCCCCHHHH | 38.49 | 29255136 | |
| 145 | Ubiquitination | DSPGKQDTEEDEEED CCCCCCCCCCCHHHH | 38.49 | 22817900 | |
| 147 | Ubiquitination | PGKQDTEEDEEEDEK CCCCCCCCCHHHHHH | 73.20 | 21890473 | |
| 153 | Ubiquitination | EEDEEEDEKDKGKLK CCCHHHHHHHCCCCC | 67.45 | 24816145 | |
| 157 | Ubiquitination | EEDEKDKGKLKPNLG HHHHHHCCCCCCCCC | 51.14 | 24816145 | |
| 160 | Ubiquitination | EKDKGKLKPNLGNGA HHHCCCCCCCCCCCC | 35.03 | - | |
| 162 | Ubiquitination | DKGKLKPNLGNGADL HCCCCCCCCCCCCCC | 60.02 | 22817900 | |
| 163 | Ubiquitination | KGKLKPNLGNGADLP CCCCCCCCCCCCCCC | 8.38 | 22817900 | |
| 166 | Ubiquitination | LKPNLGNGADLPNYR CCCCCCCCCCCCCCC | 20.76 | 22817900 | |
| 172 | Phosphorylation | NGADLPNYRWTQTLS CCCCCCCCCCCCCHH | 12.94 | 26074081 | |
| 179 | Phosphorylation | YRWTQTLSELDLAVP CCCCCCHHHHCCCCC | 39.23 | 28348404 | |
| 179 | Ubiquitination | YRWTQTLSELDLAVP CCCCCCHHHHCCCCC | 39.23 | 22817900 | |
| 180 | Ubiquitination | RWTQTLSELDLAVPF CCCCCHHHHCCCCCE | 49.79 | 22817900 | |
| 183 | Ubiquitination | QTLSELDLAVPFCVN CCHHHHCCCCCEEEE | 8.94 | 22817900 | |
| 184 | Ubiquitination | TLSELDLAVPFCVNF CHHHHCCCCCEEEEE | 13.45 | 22817900 | |
| 194 | Acetylation | FCVNFRLKGKDMVVD EEEEEEECCCCEEEE | 60.71 | 23749302 | |
| 194 | Ubiquitination | FCVNFRLKGKDMVVD EEEEEEECCCCEEEE | 60.71 | 22817900 | |
| 196 | 2-Hydroxyisobutyrylation | VNFRLKGKDMVVDIQ EEEEECCCCEEEEHH | 40.85 | - | |
| 196 | Acetylation | VNFRLKGKDMVVDIQ EEEEECCCCEEEEHH | 40.85 | 23749302 | |
| 196 | Ubiquitination | VNFRLKGKDMVVDIQ EEEEECCCCEEEEHH | 40.85 | 21906983 | |
| 198 | Sulfoxidation | FRLKGKDMVVDIQRR EEECCCCEEEEHHHH | 3.45 | 21406390 | |
| 198 | Ubiquitination | FRLKGKDMVVDIQRR EEECCCCEEEEHHHH | 3.45 | 22817900 | |
| 200 | Ubiquitination | LKGKDMVVDIQRRHL ECCCCEEEEHHHHHH | 4.27 | 21890473 | |
| 202 | Ubiquitination | GKDMVVDIQRRHLRV CCCEEEEHHHHHHHC | 2.01 | 22817900 | |
| 204 | Ubiquitination | DMVVDIQRRHLRVGL CEEEEHHHHHHHCCC | 28.46 | 21890473 | |
| 212 | Ubiquitination | RHLRVGLKGQPAIID HHHHCCCCCCCEEEC | 49.96 | 21906983 | |
| 216 | Ubiquitination | VGLKGQPAIIDGELY CCCCCCCEEECCEEE | 11.95 | 22817900 | |
| 218 | Ubiquitination | LKGQPAIIDGELYNE CCCCCEEECCEEECE | 6.38 | 22817900 | |
| 219 | Ubiquitination | KGQPAIIDGELYNEV CCCCEEECCEEECEE | 38.10 | 22817900 | |
| 220 | Ubiquitination | GQPAIIDGELYNEVK CCCEEECCEEECEEE | 19.19 | 22817900 | |
| 223 | Phosphorylation | AIIDGELYNEVKVEE EEECCEEECEEEEEE | 12.65 | 20068231 | |
| 226 | Ubiquitination | DGELYNEVKVEESSW CCEEECEEEEEECEE | 8.19 | 21890473 | |
| 231 | Phosphorylation | NEVKVEESSWLIEDG CEEEEEECEEEEECC | 17.20 | 24905233 | |
| 232 | Phosphorylation | EVKVEESSWLIEDGK EEEEEECEEEEECCE | 29.22 | 24905233 | |
| 239 | Acetylation | SWLIEDGKVVTVHLE EEEEECCEEEEEEEE | 45.94 | 19608861 | |
| 239 | Ubiquitination | SWLIEDGKVVTVHLE EEEEECCEEEEEEEE | 45.94 | 32015554 | |
| 240 | Ubiquitination | WLIEDGKVVTVHLEK EEEECCEEEEEEEEH | 5.51 | 24816145 | |
| 247 | 2-Hydroxyisobutyrylation | VVTVHLEKINKMEWW EEEEEEEHHCCHHHH | 58.92 | - | |
| 248 | Ubiquitination | VTVHLEKINKMEWWS EEEEEEHHCCHHHHH | 4.35 | 27667366 | |
| 250 | Acetylation | VHLEKINKMEWWSRL EEEEHHCCHHHHHHH | 41.49 | 25953088 | |
| 250 | Ubiquitination | VHLEKINKMEWWSRL EEEEHHCCHHHHHHH | 41.49 | - | |
| 251 | Ubiquitination | HLEKINKMEWWSRLV EEEHHCCHHHHHHHH | 4.50 | 22817900 | |
| 253 | Ubiquitination | EKINKMEWWSRLVSS EHHCCHHHHHHHHCC | 8.54 | 21890473 | |
| 255 | Phosphorylation | INKMEWWSRLVSSDP HCCHHHHHHHHCCCC | 19.46 | 27273156 | |
| 255 | Ubiquitination | INKMEWWSRLVSSDP HCCHHHHHHHHCCCC | 19.46 | 22817900 | |
| 257 | Ubiquitination | KMEWWSRLVSSDPEI CHHHHHHHHCCCCCC | 3.50 | 21890473 | |
| 259 | Phosphorylation | EWWSRLVSSDPEINT HHHHHHHCCCCCCCC | 33.35 | 27273156 | |
| 259 | Ubiquitination | EWWSRLVSSDPEINT HHHHHHHCCCCCCCC | 33.35 | 22817900 | |
| 260 | Phosphorylation | WWSRLVSSDPEINTK HHHHHHCCCCCCCCC | 50.10 | 23401153 | |
| 260 | Ubiquitination | WWSRLVSSDPEINTK HHHHHHCCCCCCCCC | 50.10 | 22817900 | |
| 265 | Ubiquitination | VSSDPEINTKKINPE HCCCCCCCCCCCCCC | 44.15 | 22817900 | |
| 266 | Phosphorylation | SSDPEINTKKINPEN CCCCCCCCCCCCCCC | 39.10 | 23186163 | |
| 266 | Ubiquitination | SSDPEINTKKINPEN CCCCCCCCCCCCCCC | 39.10 | 21890473 | |
| 267 | 2-Hydroxyisobutyrylation | SDPEINTKKINPENS CCCCCCCCCCCCCCC | 47.36 | - | |
| 267 | Acetylation | SDPEINTKKINPENS CCCCCCCCCCCCCCC | 47.36 | 25953088 | |
| 267 | Ubiquitination | SDPEINTKKINPENS CCCCCCCCCCCCCCC | 47.36 | 21906983 | |
| 268 | Acetylation | DPEINTKKINPENSK CCCCCCCCCCCCCCC | 45.75 | 25953088 | |
| 268 | Ubiquitination | DPEINTKKINPENSK CCCCCCCCCCCCCCC | 45.75 | 22817900 | |
| 269 | Ubiquitination | PEINTKKINPENSKL CCCCCCCCCCCCCCC | 12.70 | 22817900 | |
| 271 | Ubiquitination | INTKKINPENSKLSD CCCCCCCCCCCCCCC | 45.69 | 22817900 | |
| 272 | Ubiquitination | NTKKINPENSKLSDL CCCCCCCCCCCCCCC | 70.42 | 22817900 | |
| 273 | Ubiquitination | TKKINPENSKLSDLD CCCCCCCCCCCCCCC | 45.78 | 22817900 | |
| 274 | Phosphorylation | KKINPENSKLSDLDS CCCCCCCCCCCCCCH | 33.06 | 29255136 | |
| 275 | Acetylation | KINPENSKLSDLDSE CCCCCCCCCCCCCHH | 64.69 | 23236377 | |
| 275 | Ubiquitination | KINPENSKLSDLDSE CCCCCCCCCCCCCHH | 64.69 | 23000965 | |
| 276 | Ubiquitination | INPENSKLSDLDSET CCCCCCCCCCCCHHH | 4.90 | 22817900 | |
| 277 | Phosphorylation | NPENSKLSDLDSETR CCCCCCCCCCCHHHH | 39.60 | 29255136 | |
| 278 | Ubiquitination | PENSKLSDLDSETRS CCCCCCCCCCHHHHH | 66.00 | 22505724 | |
| 279 | Ubiquitination | ENSKLSDLDSETRSM CCCCCCCCCHHHHHH | 7.58 | 21890473 | |
| 281 | Phosphorylation | SKLSDLDSETRSMVE CCCCCCCHHHHHHHH | 48.44 | 29255136 | |
| 283 | Phosphorylation | LSDLDSETRSMVEKM CCCCCHHHHHHHHHH | 31.81 | 29255136 | |
| 283 | Ubiquitination | LSDLDSETRSMVEKM CCCCCHHHHHHHHHH | 31.81 | 21890473 | |
| 285 | Phosphorylation | DLDSETRSMVEKMMY CCCHHHHHHHHHHHH | 34.30 | 25159151 | |
| 289 | 2-Hydroxyisobutyrylation | ETRSMVEKMMYDQRQ HHHHHHHHHHHHHHH | 19.98 | - | |
| 289 | Ubiquitination | ETRSMVEKMMYDQRQ HHHHHHHHHHHHHHH | 19.98 | 24816145 | |
| 292 | Phosphorylation | SMVEKMMYDQRQKSM HHHHHHHHHHHHHHC | 12.86 | - | |
| 293 | Ubiquitination | MVEKMMYDQRQKSMG HHHHHHHHHHHHHCC | 21.20 | 24816145 | |
| 297 | Ubiquitination | MMYDQRQKSMGLPTS HHHHHHHHHCCCCCC | 44.60 | 27667366 | |
| 298 | Phosphorylation | MYDQRQKSMGLPTSD HHHHHHHHCCCCCCH | 15.11 | 25159151 | |
| 299 | Sulfoxidation | YDQRQKSMGLPTSDE HHHHHHHCCCCCCHH | 9.12 | 21406390 | |
| 301 | Ubiquitination | QRQKSMGLPTSDEQK HHHHHCCCCCCHHHH | 2.91 | 27667366 | |
| 303 | Phosphorylation | QKSMGLPTSDEQKKQ HHHCCCCCCHHHHHH | 54.58 | 24114839 | |
| 304 | Phosphorylation | KSMGLPTSDEQKKQE HHCCCCCCHHHHHHH | 36.89 | 25159151 | |
| 305 | Ubiquitination | SMGLPTSDEQKKQEI HCCCCCCHHHHHHHH | 65.90 | 27667366 | |
| 308 | 2-Hydroxyisobutyrylation | LPTSDEQKKQEILKK CCCCHHHHHHHHHHH | 55.14 | - | |
| 308 | Ubiquitination | LPTSDEQKKQEILKK CCCCHHHHHHHHHHH | 55.14 | 21906983 | |
| 309 | Ubiquitination | PTSDEQKKQEILKKF CCCHHHHHHHHHHHH | 53.51 | 22817900 | |
| 312 | Ubiquitination | DEQKKQEILKKFMDQ HHHHHHHHHHHHHHH | 6.73 | 22817900 | |
| 313 | Ubiquitination | EQKKQEILKKFMDQH HHHHHHHHHHHHHHC | 4.93 | 22817900 | |
| 314 | Ubiquitination | QKKQEILKKFMDQHP HHHHHHHHHHHHHCC | 50.02 | 22817900 | |
| 315 | Acetylation | KKQEILKKFMDQHPE HHHHHHHHHHHHCCC | 42.34 | 25953088 | |
| 315 | Ubiquitination | KKQEILKKFMDQHPE HHHHHHHHHHHHCCC | 42.34 | 21906983 | |
| 316 | Ubiquitination | KQEILKKFMDQHPEM HHHHHHHHHHHCCCC | 6.62 | 22817900 | |
| 317 | Sulfoxidation | QEILKKFMDQHPEMD HHHHHHHHHHCCCCC | 7.14 | 21406390 | |
| 317 | Ubiquitination | QEILKKFMDQHPEMD HHHHHHHHHHCCCCC | 7.14 | 22817900 | |
| 318 | Ubiquitination | EILKKFMDQHPEMDF HHHHHHHHHCCCCCH | 46.93 | 22817900 | |
| 319 | Ubiquitination | ILKKFMDQHPEMDFS HHHHHHHHCCCCCHH | 42.10 | 21890473 | |
| 322 | Ubiquitination | KFMDQHPEMDFSKAK HHHHHCCCCCHHHHC | 49.62 | 22817900 | |
| 323 | Sulfoxidation | FMDQHPEMDFSKAKF HHHHCCCCCHHHHCC | 8.10 | 30846556 | |
| 323 | Ubiquitination | FMDQHPEMDFSKAKF HHHHCCCCCHHHHCC | 8.10 | 21890473 | |
| 324 | Ubiquitination | MDQHPEMDFSKAKFN HHHCCCCCHHHHCCC | 42.90 | 22817900 | |
| 325 | Ubiquitination | DQHPEMDFSKAKFN- HHCCCCCHHHHCCC- | 8.56 | 22817900 | |
| 326 | Phosphorylation | QHPEMDFSKAKFN-- HCCCCCHHHHCCC-- | 27.69 | 19060867 | |
| 327 | 2-Hydroxyisobutyrylation | HPEMDFSKAKFN--- CCCCCHHHHCCC--- | 56.44 | - | |
| 327 | Acetylation | HPEMDFSKAKFN--- CCCCCHHHHCCC--- | 56.44 | 25953088 | |
| 327 | Methylation | HPEMDFSKAKFN--- CCCCCHHHHCCC--- | 56.44 | 42360665 | |
| 327 | Ubiquitination | HPEMDFSKAKFN--- CCCCCHHHHCCC--- | 56.44 | 21906983 | |
| 328 | Ubiquitination | PEMDFSKAKFN---- CCCCHHHHCCC---- | 22.07 | 22817900 | |
| 329 | Methylation | EMDFSKAKFN----- CCCHHHHCCC----- | 49.53 | 115974295 | |
| 329 | Ubiquitination | EMDFSKAKFN----- CCCHHHHCCC----- | 49.53 | 22817900 | |
| 331 | Ubiquitination | DFSKAKFN------- CHHHHCCC------- | 50.72 | 22505724 | |
| 332 | Ubiquitination | FSKAKFN-------- HHHHCCC-------- | 21890473 | ||
| 335 | Ubiquitination | AKFN----------- HCCC----------- | 22505724 | ||
| 336 | Ubiquitination | KFN------------ CCC------------ | 21890473 | ||
| 346 | Ubiquitination | ---------------------- ---------------------- | 24816145 | ||
| 350 | Ubiquitination | -------------------------- -------------------------- | 24816145 | ||
| 354 | Ubiquitination | ------------------------------ ------------------------------ | 27667366 | ||
| 358 | Ubiquitination | ---------------------------------- ---------------------------------- | 27667366 | ||
| 365 | Ubiquitination | ----------------------------------------- ----------------------------------------- | 22817900 | ||
| 366 | Ubiquitination | ------------------------------------------ ------------------------------------------ | 22817900 | ||
| 369 | Ubiquitination | --------------------------------------------- --------------------------------------------- | 22817900 | ||
| 370 | Ubiquitination | ---------------------------------------------- ---------------------------------------------- | 22817900 | ||
| 371 | Ubiquitination | ----------------------------------------------- ----------------------------------------------- | 22817900 | ||
| 372 | Ubiquitination | ------------------------------------------------ ------------------------------------------------ | 21890473 | ||
| 375 | Ubiquitination | --------------------------------------------------- --------------------------------------------------- | 22817900 | ||
| 376 | Ubiquitination | ---------------------------------------------------- ---------------------------------------------------- | 21890473 | ||
| 384 | Ubiquitination | ------------------------------------------------------------ ------------------------------------------------------------ | 22505724 | ||
| 388 | Ubiquitination | ---------------------------------------------------------------- ---------------------------------------------------------------- | 22505724 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUDC_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PLK1_HUMAN | PLK1 | physical | 12852857 | |
| LIS1_HUMAN | PAFAH1B1 | physical | 9601647 | |
| LIS1_HUMAN | PAFAH1B1 | physical | 20675372 | |
| HS90A_HUMAN | HSP90AA1 | physical | 20675372 | |
| TRM1_HUMAN | TRMT1 | physical | 22939629 | |
| PPME1_HUMAN | PPME1 | physical | 22939629 | |
| ERF1_HUMAN | ETF1 | physical | 22863883 | |
| H33_HUMAN | H3F3A | physical | 22863883 | |
| SYK_HUMAN | KARS | physical | 22863883 | |
| PAPOA_HUMAN | PAPOLA | physical | 22863883 | |
| TLN1_HUMAN | TLN1 | physical | 22863883 | |
| DNJA2_HUMAN | DNAJA2 | physical | 25036637 | |
| DNJB1_HUMAN | DNAJB1 | physical | 25036637 | |
| MAEL_HUMAN | MAEL | physical | 25036637 | |
| DNJA1_HUMAN | DNAJA1 | physical | 25036637 | |
| RS17_HUMAN | RPS17 | physical | 25036637 | |
| ADAM9_HUMAN | ADAM9 | physical | 26344197 | |
| ICAL_HUMAN | CAST | physical | 26344197 | |
| CCDC6_HUMAN | CCDC6 | physical | 26344197 | |
| G3P_HUMAN | GAPDH | physical | 26344197 | |
| SODC_HUMAN | SOD1 | physical | 26344197 | |
| EMAL4_HUMAN | EML4 | physical | 25789526 | |
| WDR35_HUMAN | WDR35 | physical | 27173435 | |
| IF172_HUMAN | IFT172 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-239, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-281, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139; THR-145 ANDSER-285, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND THR-145, ANDMASS SPECTROMETRY. | |
| "A role for Plk1 phosphorylation of NudC in cytokinesis."; Zhou T., Aumais J.P., Liu X., Yu-Lee L.-Y., Erikson R.L.; Dev. Cell 5:127-138(2003). Cited for: FUNCTION, INTERACTION WITH PLK1, IDENTIFICATION IN A COMPLEX WITHDYNACTIN AND DYNEIN, MUTAGENESIS OF SER-274 AND SER-326, ANDPHOSPHORYLATION AT SER-274 AND SER-326. | |